KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability: 2009-2024

Historic Non-Current Deferred Tax Liability for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $11.3 million.

  • Idexx Laboratories' Non-Current Deferred Tax Liability fell 34.18% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 34.18%. This contributed to the annual value of $11.3 million for FY2024, which is 89.84% down from last year.
  • Idexx Laboratories' Non-Current Deferred Tax Liability amounted to $11.3 million in FY2024, which was down 89.84% from $111.3 million recorded in FY2023.
  • Idexx Laboratories' Non-Current Deferred Tax Liability's 5-year high stood at $111.3 million during FY2023, with a 5-year trough of $11.3 million in FY2024.
  • In the last 3 years, Idexx Laboratories' Non-Current Deferred Tax Liability had a median value of $97.3 million in 2022 and averaged $73.3 million.
  • As far as peak fluctuations go, Idexx Laboratories' Non-Current Deferred Tax Liability rose by 25.26% in 2020, and later plummeted by 89.84% in 2024.
  • Idexx Laboratories' Non-Current Deferred Tax Liability (Yearly) stood at $102.7 million in 2020, then increased by 3.92% to $106.7 million in 2021, then fell by 8.77% to $97.3 million in 2022, then increased by 14.38% to $111.3 million in 2023, then crashed by 89.84% to $11.3 million in 2024.